If AstraZeneca goes to the US, it will be a major blow for London and Labour
Move would deprive LSE of its biggest star and could topple a key pillar of the government’s industrial strategy Three years ago Pascal Soriot received the ultimate accolade for turning around AstraZeneca – a knighthood for services to UK life sciences and leadership in the global response to the (...)
Site référencé: The Guardian
AstraZeneca, Business, Pharmaceuticals industry, London Stock Exchange, Industrial policy, Politics, Labour, UK news
5353.jpg?width=140&quality=85&auto=format&fit=max&s=93b728c40aa4d3b43e85598e8ca6f83d, 5353.jpg?width=460&quality=85&auto=format&fit=max&s=8975c487edd09145e98f1e9a6f9b5cd1
The Guardian
Nearly 1,000 Britons will keep shorter working week after trial
3/07/2025
Republican voters on Trump’s sweeping tax-and-spend legislation : ‘This bill is a no-brainer !’
2/07/2025
London is leaving the door wide open to private equity raiders | Nils Pratley
2/07/2025
Glastonbury ticket cost has damaged the festival’s diversity | Letter
2/07/2025
UK financial watchdog expands bullying rules to 37,000 City firms
2/07/2025
Santander takeover of TSB is boost to Reeves as she fights to keep City’s trust
2/07/2025
